Prior research has indicated heightened sFlt-1 levels and diminished PlGF levels in patients with preeclampsia, even prior to clinical symptom manifestation, making them vital indicators for screening, predicting, and diagnosing preeclampsia [4]. This evidence concerns the gene PGF and preeclampsia.